These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30335475)
1. Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank. Haslacher H; Gerner M; Hofer P; Jurkowitsch A; Hainfellner J; Kain R; Wagner OF; Perkmann T Biopreserv Biobank; 2018 Dec; 16(6):477-482. PubMed ID: 30335475 [No Abstract] [Full Text] [Related]
2. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization. Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364 [TBL] [Abstract][Full Text] [Related]
3. Improving Academic Biobank Value and Sustainability Through an Outputs Focus. Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220 [TBL] [Abstract][Full Text] [Related]
4. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks. Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912 [TBL] [Abstract][Full Text] [Related]
5. Advancing Professionalization of Biobank Business Operations: Performance and Utilization. Henderson MK; Goldring K; Simeon-Dubach D Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630 [TBL] [Abstract][Full Text] [Related]
7. Lessons Learned During Three Decades of Operations of Two Prospective Bioresources. Grizzle WE; Sexton KC; McGarvey D; Menchhofen ZV; LiVolsi V Biopreserv Biobank; 2018 Dec; 16(6):483-492. PubMed ID: 30457879 [TBL] [Abstract][Full Text] [Related]
8. An Approach to Evaluate the Costs and Outputs of Academic Biobanks. Rush A; ; Catchpoole DR; Watson PH; Byrne JA Biopreserv Biobank; 2024 Oct; 22(5):463-474. PubMed ID: 38666406 [TBL] [Abstract][Full Text] [Related]
9. A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS. Norlin L; Fransson MN; Eriksson M; Merino-Martinez R; Anderberg M; Kurtovic S; Litton JE Biopreserv Biobank; 2012 Aug; 10(4):343-8. PubMed ID: 24849882 [TBL] [Abstract][Full Text] [Related]
10. Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts. Kaye J; Briceño Moraia L; Mitchell C; Bell J; Bovenberg JA; Tassé AM; Knoppers BM Biopreserv Biobank; 2016 Jun; 14(3):201-6. PubMed ID: 27183185 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a network-based intra-hospital virtual cancer biobank. Zhang L; Wu X; Hu Y; Wang X; He Z; Xie Y; Pan K; Wang N; Dong Z; Zhang L; Ji J Biopreserv Biobank; 2015 Feb; 13(1):43-8. PubMed ID: 25686047 [TBL] [Abstract][Full Text] [Related]
12. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study. Langhof H; Kahrass H; Illig T; Jahns R; Strech D Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824 [TBL] [Abstract][Full Text] [Related]
13. Impact of biobanks on research outcomes in rare diseases: a systematic review. Garcia M; Downs J; Russell A; Wang W Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920 [TBL] [Abstract][Full Text] [Related]
14. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank. Calleros L; Cortés MA; Luengo A; Mora I; Guijarro B; Martín P; Ortiz-Arduán A; Selgas R; Rodríguez-Puyol D; Rodríguez-Puyol M Nefrologia; 2012; 32(1):28-34. PubMed ID: 22294002 [TBL] [Abstract][Full Text] [Related]
15. Biobank bootstrapping: is biobank sustainability possible through cost recovery? Albert M; Bartlett J; Johnston RN; Schacter B; Watson P Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148 [TBL] [Abstract][Full Text] [Related]
16. Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research. Zelisse HS; van Gent MDJM; de Ridder S; van der Aa MA; van Altena AM; Bart J; Belien JAM; Boere IA; Bosch SL; Broeks A; Bulten J; Collée M; Groenendijk FH; Horlings HM; Jansen MPHM; Jonges TGN; Kooreman LFS; de Kroon CD; Lambrechts S; Lok CAR; Piek JM; Reyners AKL; Roes EM; Simons M; Wisman GBA; Yigit R; Zweemer RP; Mom CH; van de Vijver MJ; Dijk F; Gynecol Obstet Invest; 2022; 87(6):389-397. PubMed ID: 36450222 [TBL] [Abstract][Full Text] [Related]
17. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study. Parry-Jones A Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149 [TBL] [Abstract][Full Text] [Related]
18. Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output. Hofman V; Ilie M; Long E; Washetine K; Chabannon C; Figarella-Branger D; Clément B; Mabile L; Cambon-Thomsen A; Boucher P; Dagher G; Hewitt R; Parodi B; Hofman P Biopreserv Biobank; 2013 Aug; 11(4):235-44. PubMed ID: 24845591 [TBL] [Abstract][Full Text] [Related]
19. Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in Canada. Tarling T; Matzke LAM; Rush A; Gali B; Byrne JA; Watson PH Biopreserv Biobank; 2022 Feb; 20(1):75-83. PubMed ID: 34165356 [No Abstract] [Full Text] [Related]
20. Analysis of the research sample collections of Uppsala biobank. Engelmark MT; Beskow AH Biopreserv Biobank; 2014 Oct; 12(5):325-31. PubMed ID: 25340941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]